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1. Introduction 
Liver surgery underwent enormous evolution after development and introduction of new 
technical skills in surgical praxis. Nevertheless many patients with primary or secondary 
liver malignancies are not indicated to radical surgical therapy that could reach complete 
remission of malignant disease because the frontiers of liver surgery are limited today by the 
functional reserves of remnant parenchyma. The main argument to non surgical treatment is 
increased risk of acute liver failure after extended liver resection, where retained liver 
parenchyma is to small to sustain the liver functions (Abdalla, 2001). Portal vein 
embolization (PVE) can multiply the future liver remnant volume (FLRV) in spite of 
affection of only one of liver lobes by malignant diseases (Makuuchi, 1984, Makuuchi, 1990, 
Harada, 1997). This procedure was performed firstly in 1984 by Makuuchi (Abdalla, 2001, 
Makuuchi, 1984, Makuuchi, 1990). PVE of portal branch of with malignancy afflicted liver 
lobe initiates compensatory hypertrophy of contralateral non-occluded lobe. The occluded 
lobe underlies atrophy. The compensatory hypertrophy is supposed to be stimulated by 
increased flow of portal blood, that contains hepatotrophic substances (Kusaka, 2004, 
Azoulay, 2000). Liver resection after PVE is performed only in 63-96% of patients (Kokudo, 
200, Stefano, 2005, Lagasse, 2000). The main reason for this resolution is unsuccessful 
hypertrophy of FLRV or progression of malignancy. Liver resection after PVE is performed 
only in 63-96% of patients (Azoulay, 200, Kokudo, 2001, Stefano, 2005). The main reason for 
this resolution are unsuccessful hypertrophy of FLRV or progression of malignancy. 
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The proper regeneration of liver parenchyma depends on proliferation of parenchymal and 
non-parenchymal liver cells. The importance of stem cells or liver oval cells is still under 
discussion and this mechanism provokes many questions (Lagasse, 2000, Petersen, 1999, 
Vassilopoulos, 2003). After partial hepatectomy or portal vein ligation increase serum levels 
of Tumour necrosis factor alpha (TNF-ǂ) and Interleukin-6 (IL-6), which were demonstrated 
to be involved in priming of hepatocytes and trigger them from G0 to G1 cell cycle 
phase(Cornell, 1990). These cytokines induce gene activation, which are responsible for G1 
phase. Both pleiotrophic cytokines are secreted by non-parenchymal liver cells (mostly 
Kupffer cells) (Fausto, 2000, Fausto, 2005). TNF-ǂ is superior to IL-6 and stimulates 
increased secretion of IL-6. In hepatectomized regenerating liver, it is known that this 
signaling pathway follows the sequence TNF-ǂ → TNFR-1 → NFκB → IL-6 → STAT3 
(Michalopoulos, 1997). The proliferation of primed hepatocytes is regulated positively by 
Hepatocyte growth factor (HGF), Epidermal growth factor (EGF), Insulin-like growth factor 
(IGF), Transforming growth factor-alpha (TGF-ǂ), etc. The termination of proliferation and 
stimulation of hepatocyte to differentiation, final remodelation of liver tissue and 
production of extracellular matrix is controled by Transforming growth factor-beta (TGF-ǃ) 
(Fukuhara, 2003, Mangnall, 2003, Zimmermann, 2004). TGF-ǃ1 plays the most important 
role in starting the remodelling of the extracellular matrix and restoration of the original 
structure of the liver parenchyma. TGF-ǃ1 inhibits DNA synthesis and plays a pivotal role 
in the down-regulation of liver regeneration as has been demonstrated in toxic models of 
liver regeneration (Armendariz-Borunda, 1993, Armendariz-Borunda, 1997). TGF-ǃ1 also 
down-regulates the production of the Hepatocyte growth factor that sustains hepatocyte 
proliferation (Bustos, 2000). Increased expression of TGF-ǃ1 prevents uncontrolled growth 
during liver regeneration by the regulation of hepatocyte transition from the G1 to the 
S phase of the cell cycle (Kusaka, 2006, Oe, 2004). TGF-ǃ1 helps maintain the differentiation 
of hepatocytes and non-parenchymal liver cells. The proposed HGF/ TGF-ǃ1 ratio could 
reflect the proliferation/differentiation status of hepatocytes (Lilja, 1999). Increased 
expression of TGF-ǃ1 was also shown to be a crucial factor for the progression of hepatic 
fibrosis (Friedman, 2008). This could be explained by increased or prolonged production of 
the liver extracellular matrix (Viebahn, 2008). 
The replication of hepatocytes culminates on 7th days (14per cent of hepatocytes) and the 
return to quiscent status was observed on 12th day after PVE in swine experimental model 
(Coelho, 2007, Duncan, 1999). The differencies between PVE and PVL (portal vein ligation) 
were not proved as statistical significant for reached FLRV (Broering, 2002).  
Multipotent mesenchymal stromal cells (MSC) are a fraction of the adult bone marrow stem 
cell compartment. They contain a subpopulation of mesenchymal stem cells that can 
differentiate into mesenchymal adult tissues under specified conditions. Differentiation into 
adipocytes, chondrocytes, osteoblasts and myocytes has been demonstrated in vitro and in 
vivo (Barry, 2003). Whether and how bone marrow-derived stem cells, and MSC in 
particular, can contribute to liver regeneration is not entirely clear. Initital reports outlined that 
bone marrow-derived (stem) cells can transdifferentiate into liver cells or their progenitors 
after bone marrow transplantation (Jiang, 2002, Lagasse, 2000, Petersen, 1999, Ringe, 2002). 
Later investigations clarified and complemented these observations, outlining that bone 
marrow cells can also fuse with resident liver cells (Vassilopoulos, 2003, Wang, 2003). In 
addition to direct cellular effects, transplanted bone marrow cells can also contribute to liver 
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regeneration by bystander effects, such as the provision of a beneficial proliferative cytokine 
milieu or antiapoptotic effects (Aldeguer, 2002, Dahlke, 2004, Liska, 2009). 
The aim of presented studies was to influence regeneration of liver parenchyma after portal 
vein embolization/ligation by exogenous cytokines, growth factors and monoclonal 
antibodies against growth factors with inhibitory funcions or syngeneic Multipotent 
Mesenchymal Stromal Cells. 
2. Methods 
2.1 Surgical procedure 
All described procedures were prepared and performed after by law of Czech Republic, 
which is compatible with legislature of European Union. The experimental animal was 
piglet. The experimental porcine model was established to be as much compatible as 
possible with PVE/PVL in human medicine. 
There were no statistical differencies in weight and age of the piglets undergoing portal vein 
ligation. The animals were housed under same conditions. In this study there were included 
9 piglets in control group, 9 piglets in TNF-ǂ group, 8 piglets in IL-6 group, 6 piglets in MSC 
group and 7 piglets in MAB TGF-ǃ1 group. 
The piglets were premedicated intramuscularly with atropine 1,5 mg and azaperon 1,0 
mg/kg. The anesthesia was administered continually through central venous catheter in 
whole average doses: azaperon 1,0 mg/kg/hour, thiopental 10 mg/kg/hour, ketamin 5-10 
mg/kg/hour and fentanyl 1-2 ug/kg/hour. The muscle relaxation was provided by bolus 
administration of pancuronium 0,1-0,2 mg/kg at the begin of surgery. Animals were 
intubated and mechanically ventilated during surgical procedure. The monitoring of 
electrocardiogram, oxygen saturation and central venous pressure was performed. The 
surgical procedure was performed under aseptic and antiseptic conditions. The antibiotic 
prophylaxis was administered in total dosis of 1,2 g amoxicillin with clavulanic acid divided 
into two doses (before surgery and two hours later). 
The middle laparotomy was performed. The portal vein branches for caudate, right lateral 
and right medial lobes (50-60 per cent of supposed liver parenchyma) were prepared and 
ligated without injury or ligation of hepatic artery branches. The blood flow in hepatic 
artery branches and occlusion of portal vein branches were controled by Doppler 
ultrasonography (Medison Sonoace 9900, linear probe with frequency 7,5 MHz, Fig.1). The 
borders between atrophic and hypertrophic liver lobes were marked by titanium staples to 
simplify the postoperative ultrasonography. 
The recombinant porcine TNF-ǂ in amount 5μg/kilos (rpTNF-ǂ, ProSpec TechnoGene, 
Israel, 9 piglets from TNF-ǂ group), the recombinant porcine IL-6 in amount 0,5μg/kg (rpIL-
6, ProSpec TechnoGene, Israel, 8 piglets from Il-6 group), MSC (autologous bone marrow 
stem cells cultured in expansion medium (low glucose DMEM with GlutaMAX, without 
pyruvate, Biochrom) supplemented with 10% fetal bovine serum (FBS, Biochrom), 1% 
penicillin/streptomycin and 1% glutamine. After 24, 48 and 72 hours, non-adherent cells 
were removed by changing the culture medium. Adherent cells were then trypsinized (0.5% 
trypsin-EDTA), harvested and re-plated into new flasks, each time, when cell confluency 
reached 60% to 80%. To histologically identify transfused MSC within the recipient liver, 
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cultured MSC were labeled with 5-bromo-2-deoxyuridine (BrdU) 60 hours before cell 
application. 6 piglets, the amount of applied stem cells: 8.75, 14.0, 17.0, 17.5, 43.0 and 61.0 x 
106 MSC respectively) or physiological solution (9 piglets from control group) were applied 
into non-occluded portal vein branches (Liska, 2012, Liska, 2009, Liska, 2009, Teoh 2006).  
The laparotomy was closed in anatomical layers. At the end of operation the port-a-cath was 
introduced into the superior caval vein. The animals were extubated and monitored each 
day for the next fourteen days with a particular emphasis on the clinical examination 
(attention to wound healing, infection of the port-a-cath and function of the gastrointestinal 
system) to diagnose possible surgical complications. The postoperative analgezia was 
provided by intramuscular application of small dosis of Azaperon (10mg). 
Administration of MAB TGF-ǃ1 was performed into central venous catheter 24 hours after 
ligation (7 piglets, 40μg/kg of body weight) ( Armendariz-Borunda , 1993, Deneme, 2006, 
Liska, 2012).  
 
Fig. 1. Doppler ultrasonography of liver parenchyma with occluded portal vein branch and 
non occluded branch of hepatic artery (arrow). 
2.2 Biochemistry and immunoanalysis 
The blood samples were collected from central vein catheter at 1. before operation, 2. after 
ligation of the last portal branch, 3. at the end of operation, 4. 2 hours after operation, 5. 1th 
postoperative day (p.d.), 6. 3rd p.d., 7. 7th p.d., 8. 10th p.d., 9. 14th p.d.  
The following biochemical parametres were estimated by biochemical analysator Olympus 
2700: bilirubin, urea, creatinine, alkaline phosphatase (ALP), gamaglutamyltransferase 
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(GGT), cholinesterase (CHE), aspartylaminotransferase (AST), alanine aminotransferase 
(ALT) and albumin. 
Serum level of C-reactive protein (CRP), studied cytokines (TNF-ǂ and IL-6) and growth 
factors (TGF-ǃ1, IGF) were meassured by enzyme-linked immunosorbent assay (ELISA) by 
Auto-EIA II Analyzer (Lasystems Oy Helsinki, Finland).  
2.3 Ultrasonography 
The ultrasonographic controls were undertaken immediately after operation and on 3rd, 
7th, 10th and 14th postoperative day (ultrasound machine Medison Sonoace 9900, convex 
probe with frequency 3,5 MHz). The diameters of atrophic and hypertrophic (functional 
liver remnant volume) lobes were meassured in B-modus in all three basic planes (axial, 
sagittal and coronary). The volume of lobes is counted by using standard ultrasonographic 
formula, which is used also in human medicine: axial x sagittal x coronary / 2 (Liska, 2009).  
2.4 Histology 
The experiment was finished on 14th day by sacrifying of animals under general anaestesia 
with concentrated solution of potassium chloride administered into central venous catheter.  
The histological material from atrophic and hypertrophic parenchyma was examined after 
staining with hematoxyline-eosine, periodic acid-Schiff (PAS) staining and PAS staining 
after digestion of preparations with diastase. The proliferation activity was examined using 
antibody Ki67 (MIB 1 MW, 1:1000 DakoCytomation). We concentrated especially at the 
measurement of lobulus length, binucleated hepatocyte, length of hepatocytes. The amount 
of binucleated hepatocytes were measured in 20 microscopic fields by an eyepiece 
micrometer (Olympus). The size of the hepatocytes and the length of the lobuli were 
examined twice using the eyepiece micrometer (Olympus). 
2.5 Statistical analysis 
Statistical analysis was performered by sofware CRAN 2.4.0 and STATISTICA 98 Edition. 
The meassured parameters (biochemistry, immunoanalysis, ultrasonography) were 
described by basic statistical variables – mean, median, standard deviation, minimum, 
maximum and quartile extent. The statistical data were processed graphicaly into Box and 
Whisker plot diagrams. The comparison of distribution of studied parameters in groups was 
counted by distribution-free test (Wilcoxon). The Spearman Rank Correlation Coefficient 
was used because of non-Gausian distribution of parameters values. The whole 
development of studied parameters in time was compared between groups by parametric 
test ANOVA. 
3. Results 
3.1 Functional liver remnant volume 
To assess the overall functional effect of MSC infusions, rpTNF-ǂ group, rpIL-6 and MAB 
TGF-ǃ1 after partial portal vein ligation in the porcine model, the volume of the occluded 
and non-occluded liver lobes was analyzed by ultrasonography. Repeated ultrasonographic 
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assessments were carried out on p.d. 0, 3, 7, 10 and 14. The volumes of both the ligated right, 
and the non-ligated left liver lobes were computed by a standard three-dimensional 
ultrasonographic approach and were confirmed by physical examination during necropsy 
on day 14. The volume of the hypertrophic lobe increased more rapidly after MSC 
application in the treatment group when compared to the control group (Figure 2). The 
control group did not show any change in the volume of the hypertrophic liver lobes within 
the first three days after surgery. The growth acceleration of the hypertrophic liver lobes in 
the MSC group was at its maximum between the 3rd and 7th p.d. (p<0.05 versus control). 
However, this stimulating effect slowed down during the second week and there was no 
statistically significant difference in the size of the hypertrophic liver lobes on day 14. 
However, the average volume of the non-occluded liver lobe was increased by 30% in the MSC 
group in contrast to the control group at the end of the experiment (Fig. 2),( Liska, 2009).  
 
Fig. 2. Volumes of the non-ligated liver lobes are depicted for the control and the MSC-
treated group. Liver volume was assessed by 3D ultrasonographic measurements.  
In case of TNF-ǂ group the absolute volume of hypertrophic lobes increased after 
application of TNF-ǂ more rapidly wheareas the control group has no changes in 
hypertrophic liver lobes volumes in first three days. The acceleration of growth of 
hypertrophic liver lobes in TNF-ǂ group was maximal on 7th p.d. in comparisson with 
control group (p<0.05), nevertheless this stimulating effect was lost on the 14th p.d. and the 
differencies were not statistically significant (Fig.3) ,( Liska, 2012). 
The absolute volume of hypertrophic lobes grew more rapidly after application of MAB 
TGF-ǃ1, whereas the control group had a slow but continual growth in the hypertrophic 
liver lobes during the whole follow-up period. The augmentation of growth of the 
hypertrophic lobes was maximal between the 3rd and 7th postoperative days in comparison 
with the control group (p<0.05). Nevertheless this growth accelerating effect was lost during 
the next ultrasonographic controls, and on the 14th postoperative day there were no 
statistically significant differences (Fig. 4),( Liska, 2012). 
IL-6 group demonstrated growth of volume of hypertrophic lobes more rapidly after 
application of studied cytokine wheareas the control group has slow start of growth in 
hypertrophic liver lobes in first three days. The acceleration of growth of hypertrophic liver 
lobes in IL-6 group was maximal on 7th p.d. in comparisson with control group (p<0.05), 
nevertheless this stimulating effect was also lost during the follow up period and on 14th 
p.d there were no statistically significant differencies as at other experimental groups (Fig.5), 
(Liska, 2009).  
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Fig. 3. Comparison of liver hypetrophy between control group and TNF-ǂ group.  
 
Fig. 4. Comparison of the growth of hypertrophic liver lobes between TGF-ǃ1 and control 
groups.  
 
Fig. 5. Comparison of hypertrophic liver lobes growth between IL-6 group and control group. 
3.2 Biochemistry 
To outline the functional liver capacity after the infusion of MSC and to understand possible 
systemic side effects, biochemical parameters, as well as cytokine and growth factor levels 
were analyzed in sera of both animal groups during and after the intervention. All 
parameters were measured on a clinical analyzer before and during the procedure, as well 
as on p.d. 1, 3, 7, 10 and 14. Serum levels of AST and ALT increased after portal vein ligation, 
whereas serum cholestatic markers bilirubin, ALP and GGT remained stable. Synthetic liver 
function was unchanged with normal levels of CHE (Fig. 6). There was no difference  
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Fig. 6. Comparison of serum biochemistry during the postoperative period between MSC 
and control group: Blood was drawn from piglets before and during the procedure, as well 
as on postoperative days 1, 3, 7, 10 and 14. Liver function tests and other biochemical 
markers were measured on a clinical analyzer and are depicted as mean +/- standard 
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deviation. (ALB=serum albumin, ALT=alanine aminotransferase, CHE=cholinesterase, 
BI=serum bilirubin and growth factors TGFb1, IGF and HGF).  
between the MSC-treated and the control group regarding these markers. Serum CRP levels 
were elevated to the same extent in all animals during the postoperative period. Kidney 
function was stable in all piglets with physiological levels of creatinine and urea (Fig.6). 
Overall, all treated animals of both groups tolerated the treatment well with neither 
apparent differences in the clinical course or the biochemistry markers assessed. To describe 
the regenerative micromilieu within recipient livers, the secretion of growth factors HGF, 
IGF, TGFǃ1 and TNFǂ was analysed in sera of all animals over time. Both groups expressed 
the same pattern of TGFß1, IGF and TNFǂ in the periphery with a tendency towards 
decrease of TGFß1 and IGF in the early phase and stable TNFǂ. HGF expression was slightly 
higher in the control group early after the procedure. Nevertheless, there were no proved 
statistical differences between studied cytokines and growth factors in particular time 
points. Overall, the cytokine expression pattern in the periphery indicates that differences in 
the extent of postoperative liver hypertrophy between the groups are most likely due to 
micromilieu changes within defined anatomical spaces in the liver (Liska, 2009). 
The serum levels of all studied biochemical and immunological parameteres compared 
between TNF-ǂ and control group are presented in figure 7 and 8. The serum levels of all 
studied biochemical parameters achieved no statistically signifficant differences. The other 
studied serum biochemical parameteres were comparable in both experimental groups and 
the differences did not prove any statistical significancy. 
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Fig. 7. Comparison of serum levels of studied biochemical parametres (albumin, alkaline 
phosphatase, alanine aminotransferase, aspartate aminotransferase, bilirubin, C-reactive 
protein, gamaglutamyltransferase, cholinesterase, creatinine and urea) between TNF-ǂ and 
control groups during liver hypertrophy. (1) before operation, (2) after ligation of the last 
portal branch, (3) 30 minutes after partial portal vein ligation – application of TNF-ǂ or 
physiological solution, (4) 2 hours after partial portal vein ligation, (5) 1st postoperative day 
p.d., (6) 3rd p.d., (7) 7th p.d., (8) 10th p.d., (9) 14th p.d. 
The serum level of TNF-ǂ increased after application of studied cytokine but its serum level 
got practically normalized on first p.d. (p-value<0.05) (fig.8). The serum levels of all other 
studied cytokines and growth factors expressed no differences between TNF-ǂ and control 
group. We did not distingush any serum level changes of CRP (Liska, 2012). 
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In case of TGF-ǃ1 group the serum levels of all the studied biochemical parameters and the 
progression of curves are presented in figure 9. All studied serum biochemical parameters 
were comparable in both experimental groups and the differences shows no statistical 
significance between the TGF-ǃ1 and the control group at each timepoint (Liska, 2012).  
 
   
   
 
 
Fig. 8. Comparison of serum levels of studied cytokines and growth factors (HGF, IGF, IL-6, 
TGFǃ-1 and TNF- ǂ) between TNF-ǂ and control groups during liver hypertrophy. (1) 
before operation, (2) after ligation of the last portal branch, (3) 30 minutes after partial portal 
vein ligation – application of TNF-ǂ or physiological solution, (4) 2 hours after partial portal 
vein ligation, (5) 1st postoperative day p.d., (6) 3rd p.d., (7) 7th p.d., (8) 10th p.d., (9) 14th p.d.  
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Fig. 9. Comparison of serum levels of some of the studied biochemical parameters between 
TGF-ǃ1 and control groups. (1) before operation, (2) after ligation of the last portal branch, 
(3) 30 minutes after partial portal vein ligation, (4) 2 hours after partial portal vein ligation, 
(5) 1st postoperative day p.d. (before application of MAB TGF-ǃ1 or physiological solution), 
(6) 3rd p.d., (7) 7th p.d., (8) 10th p.d., (9) 14th p.d.  
All studied serum biochemical parameters compared between IL-6 and control groups were 
comparable and the differences did not prove any statistical significancy in each time point 
(Fig. 10). The serum levels of all studied cytokines and growth factors expressed no 
statistically significant differences between IL-6 and control group in each time point (Fig. 
11). We did not distinguish any serum level changes of CRP (Liska, 2009). 
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Fig. 10. Comparison of serum levels of studied biochemical parameters between IL-6 group 
and control group.  
   
 
Fig. 11. Comparison of serum levels of studied cytokines and growth factors between IL-6 
group and control group. 
3.3 Histology and Immunohistology 
Histological examination of liver biopsies from MSC and control groups was carried out to 
outline differences in the proliferative response and the composition and size of liver cells 
between the groups. Screening for a possible involvement of resident progenitor cells was 
also performed to try and identify the infused population of MSC. The analysis was 
performed at the time of necropsy on the 14th p.d. No overall difference in the length of liver 
lobuli was detected between the groups on H&E staining. However, a tendency towards 
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longer lobuli was demonstrated in the MSC-treated group, potentially indicating a 
bystander effect of the infused MSC on the size of liver lobuli. Although lobuli length was 
slightly increased, the size of the individual hepatocytes did not prove to be different 
between the groups and the number of binucleated hepatocytes was equal in both groups. 
Two weeks after the intervention, the intrinsic proliferative activity was low in both groups 
and the Ki67 proliferative index was practically the same as in normal liver tissue.. Only 
solitary BrdU-stained transplanted MSC were detected within the hypertrophic liver 
parenchyma (Fig. 12). 
  
Fig. 12. Identification of infused MSC: Solitary BrdU-stained MSC could be identified  
in the treatment group on day 14(a). No BrdU-positive cells were identified in control 
animals (b). 
The histological examination of biopsies from liver of TNF- ǂ and control group was burden 
by the time of collection of specimen, when the proliferative phase of liver regeneration is 
finished factically. The differences in lobulus length were not statisticaly significant (p-
value=0.08), but in the cytokine group there were not only small or normal size lobulus, but 
also many larger lobulus, which were not present in the control group. The statistical 
analysis of binucleated hepatocytes did not prove any significant differences in this studied 
histological parameteres. The length of hepatocytes was not proved also as statistically 
significant parameter. The proliferative activity in both groups was very decreased (Liska, 
2012).  
In case of comparison of TGF-ǃ1 and control group the differences in length of lobuli were 
not statistically significant (see figure 13). Statistical analysis also showed no significant  
 
Fig. 13. Comparison of length of lobuli in hypertrophic lobes between TGF-ǃ1 and control 
groups.  
BA 
    BrDU-stained MSC
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increase in the quantity of binucleated hepatocytes in the hypertrophic liver lobes in the 
TGF-ǃ1 group (see figure 14). We observed a larger distribution of the number of 
binucleated hepatocytes per field in the hypertrophic lobe from TGF-ǃ1 group (1-4 
binucleated hepatocytes per field) in contrast to the control group (2-3,5 binucleated 
hepatocytes per field). The test of normality demonstrated a normal distribution of this 
parameter in each animal in both experimental groups. The size of hepatocytes was also 
not proved to be a statistically significant parameter for differences between the TGF-ǃ1 
group and the control group (see figure 15). Proliferative activity in both groups was 
greatly reduced.  
In case of comparison of histological findings at IL-6 and control groups the differences in 
lobulus length were not statisticaly significant. The statistical analysis proved significant 
increased amount of binucleated hepatocytes in hypertrophic liver lobes in IL-6 group (fig. 
16). The length of hepatocytes was not proved also as statistically significant parameter. The 
proliferative activity in both groups was very decreased (Liska, 2009).  
 
 
Fig. 14. Comparison of the concentration of binucleated hepatocytes in hypertrophic lobes 
between TGF-ǃ1 and control groups. The binucleated hepatocytes were detected in 20 
microscopic fields. 
 
 
 
Fig. 15. Comparison of size of hepatocytes in hypertrophic lobes between TGF-ǃ1 and 
control groups. 
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Fig. 16. Comparison of concentration of binucleated hepatocytes in hypertrophic lobes 
between IL-6 group and control group. The binucleated hepatocyte were detected in 20 
microscopical fields. 
4. Discussion  
4.1 Functional liver remnant volume 
In the presented chapter the authors want to review all experiences with influence of 
experimental portal vein ligation with cytokines, monoclonal antibody against growth factor 
and mesenchymal stem cells. This model closely mimics the situation of human oncological 
liver surgery, in which portal vein embolization can be utilized to create a larger future liver 
remnant volume before resection. The clinical goal of portal vein embolization is to increase 
the number of patients that can undergo extensive liver resections. This porcine 
experimental model of liver regeneration is especially applicable to the clinical situation 
since pigs closely resemble human liver anatomy and fysiology (Liska, 2009, Liska, 2009).  
After portal venous infusion of MSC in this model, augmented and accelerated regeneration 
of the non-occluded liver lobes is outlined. This effect was strongest between the third and 
seventh postoperative day and slowly weaned off thereafter. However, there was no overall 
volume difference of statistical significance between both groups at the end of the 
observation period. This result might have been expected, though, since the body weight to 
liver weight ratio is tightly controlled in most species (Liska, 2009).  
Previous studies have tried to clarify the potential contribution of MSC to liver regeneration in 
rodent models. Most of these approaches used toxic models, in which the intrinsic self-
renewing capacity of the recipient liver was suppressed (Dahlke, 2003, Kang, 2005). Di Bonzo 
observed only 0,2% human hepatocytes after transplantation of human MSC into 
immunodeficient mice with chronic liver injury (Di Bonzo, 2008). Overall, whether MSC can 
significantly contribute to liver regeneration in vivo remains controversial (Dahlke, 2004, Lysy, 
2008, Popp, 2006), although MSC can show some features of hepatic differentiation in culture 
or under immunoprivileged conditions (Najimi, 2007, Ong, 2006). Chamberlain observed 
differentiation of human MSC into hepatocytes after infusion of MSC into foetal sheep 
(Chamberlain, 2007) and transplantable hepatocytes were also obtained from heavily growth 
factor-treated MSC (Banas, 2007, Yamamoto, 2008). Despite the fact that it was not possible to 
identify transplanted MSC within recipient livers in this model after 14 days, liver 
hypertrophy was augmented. It is therefore likely that bystander effects of the transplanted 
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MSC accelerated regeneration in this model. This effect may be well mediated through 
paracrine effects of the infused MSC on the microenvironment in the periportal regions, where 
parenchymal regeneration is initiated. Aldeguer et al. suggested that increased production of 
IL-6 by bone marrow-derived cells, for example, can stimulate intrinsic liver regeneration 
(Aldeguer, 2002). In addition to being effective in terms of an accelerated regenerative 
response, the infusion of syngenic MSC into the portal vein also proved to be safe in the 
preclinical model. Probable side effects of MSC infusions include immunological problems 
(hypersensitivity, immune complex reactions), metabolic dysregulation and emboli. None of 
these problems occured in the presented study cohort (Liska, 2009).  
The acceleration of growth of hypertrophic liver lobes after application of TNF-ǂ confirmed 
results gained at in vitro models and in experiments in small laboratory animals (Cornell, 
1990). The selected concentration of applied cytokine initiated acceleration of regeneration 
of liver parenchyma in non-occluded liver lobes (Heinrich, 2006, Teoh, 2006).  
The acceleration of growth of hypertrophic liver lobes after application of IL-6 confirmed 
results gained at in vitro models and in experiments in small laboratory animals 
(Cornell,1990, Fukuhara, 2003). The selected concentration of applied cytokine initiated 
acceleration of regeneration of liver parenchyma in non-occluded liver lobes (Baier,2006, 
Heinrich, 2006).  
We presented possibilities of the application of extrinsic MAB TGF-ǃ1 to increase the required 
future remnant liver volume after partial portal vein ligation. The absolute volume of 
hypertrophic lobes (left lateral and medial lobes) grew more rapidly after application of MAB 
TGF-ǃ1, whereas the control group had a slow but continual growth in the hypertrophic liver 
lobes during the whole follow-up period. The augmentation of growth of the hypertrophic 
lobes was maximal between the 3rd and 7th postoperative days in comparison with the control 
group (p<0.05). Nevertheless this growth accelerating effect was lost during the next 
ultrasonographic controls, and on the 14th postoperative day there were no statistically 
significant differences. The results of the presented study confirmed in large animal 
experiment previous findings gained using in vitro models and in experiments with small 
laboratory animals (Armendariz-Borunda, 1993, Armendariz-Borunda, 1997, Deneme, 2006, 
Delgado-Rizo, 1998). The selected concentration and timing of the application of monoclonal 
antibody prolonged acceleration of liver parenchyma regeneration in non-occluded liver lobes 
of animals (Armendariz-Borunda, 1993, Deneme, 2006). The secondary effects that could be 
hypothesized after application of the monoclonal antibody against key pleiotropic growth 
factor (changes in immune reactions and homeostasis) were not observed either during 
application or in the whole postoperative period. In previous described experimental groups 
(IL-6 and TNF-ǂ group) we have shown the importance and usefulness of cytokines of the first 
phase of liver regeneration that increase priming of the hepatocytes – Interleukine-6 and 
Tumor necrosis factor – ǂ (Liska, 2009, Liska, 2012), but these cytokines have pleitropic 
functions, which could be altered or changed by application of these cytokines from an 
extrinsic source. The choice of the monoclonal antibody against growth factor that terminates 
this first phase of liver regeneration and stimulates hepatocytes to differentiation, production 
of extracellular matrix and remodelation of liver tissue structure, imitates the same effect of 
these named cytokines (Kusaka, 2004). 
The present study describes a new usage of a monoclonal antibody against TGF-ǃ1 in large 
animal experimental model of partial portal vein ligation, which simulates the situation in 
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human medicine. The achieved acceleration of growth of the hypertrophic liver lobes after 
application of monoclonal antibody against TGF-ǃ1between 3rd and 7th postoperative days 
confirmed the key role of the studied cytokine in terminating the regeneration of liver 
parenchyma after portal vein ligation. The experimental results could be settings for a 
clinical study in patients with a low response regeneration of future liver remnant volume 
after portal vein embolization that does not allow surgical treatment (Liska, 2012).  
4.2 Biochemistry 
All biochemical parameters, including cytokine levels, that were assessed during the 
observation period, did not outline any significant differences between the MSC-infused 
and the control group, indicating that both groups were systemically stable throughout the 
regenerative period. Concerning the role of cytokines it may also be assumed that these act 
on a more local level within the liver parenchym and differences cannot be observed in the 
periphery (Liska, 2009). 
On the contrary application of TNF-ǂ brought the tendency to differences in serum level of 
AST, ALT, GGT and creatinine in postoperative period, which were not statistically 
significant. All these biochemical parameters could be due to operative stress and also to 
occlusion of portal branches of right liver lobes, which represent significant liver function 
reserves. The postoperative elevation of these parameters could be hypothesized also to 
atrophic changes in occluded lobes. This reduction of expected increased serum level of 
discussed biochemical parameters after application of studied cytokine in non occluded portal 
vein could present also one of its pleiotropic functions – hepatoprotection agains changes after 
operative stress and reduction of functional parenchyma (Teoh, 2006, Baier, 2006). This 
hypothesis should be probably examined on non-resection experimental model (Liska, 2012). 
We did not prove any statistically significant differences between serum levels of studied 
biochemical parameters in particular time points between IL-6 and control groups. It 
demonstrates also no unsuitable influence of applied cytokine on the liver function. The 
changes in serum levels of studied cytokines, growth factors were also not observed as 
different between IL-6 and control group in separate time points (Liska, 2009). 
In case of comparison of TGF-ǃ1 and control group no statistically significant differences 
were shown between serum levels of the studied biochemical parameters at particular 
points in time. This also demonstrates that there was no unsuitable influence of the applied 
monoclonal antibody on the liver function. This results support our ideas to choose 
monoclonal antibody against TGF-ǃ1 for future clinical studies in human liver (Liska, 2012).  
4.3 Histology and immunohistochemistry 
No histological differences were observed after 14 days between the groups (number of 
mitotic figures, binucleated hepatocytes, length of lobuli, hepatocyte size), indicating that 
the initial phase of liver regeneration had been completed in both groups and there was no 
influence of the infused MSC on liver architecture. Using BrdU staining, only very few of the 
infused MSC could be detected. Thus, injected MSC do not contribute to liver regeneration 
through proliferation, but most likely help to establish a micormilieu supportive for intrinsic 
proliferation of resident hepatocytes. Results acquired by this experimental study confirm the 
experiences of Furst and Esch, who have previously shown that cell grafts of bone marrow 
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origin (CD133 positive cells) applied after PVE in human surgery can increase the FLRV (Furst, 
2007). From the present experimental data, however, it cannot be concluded with certainty that 
the application of stem cells, including MSC, does not support the growth of liver 
malignancies to the same extent that it supports liver regeneration. Assuming a bystander 
effect of MSC on the micromilieu makes this even more likely (Alison, 2006). Thus, further 
animal investigation is necessary before optimized MSC therapies can be applied in the setting 
of human medicine (Alison, 2006). In conclusion, it has been hereby shown that the intraportal 
infusion of syngeneic porcine MSC after PVE in a setting of liver regeneration led to an 
accelerated and augmented compensatory liver hypertrophy. This effect is most likely due to 
bystander effects of the transplanted MSC (Liska, 2009). 
The increased number of larger lobulus in the hypertrophic parenchyma of TNF-ǂ group in 
comparison with control group could be explained by incomplete liver regeneration. 
Because there are practically no mitotic figures or the amount is of same quantity as in the 
normal liver parenchyma without any surgical procedures or toxic insult, we could 
hypothesize, that the first phase of liver regeneration is finished and the next phase of 
regeneration proceeds. It means the remodelation phase and the phase, when the liver 
microstructure is restored. Next would be objective to future study – the detection of 
intracellular or extracelular matrix changes during the process of liver regeneration. No 
differences in the amount of binucleated hepatocytes could be discussed also by end of 
proliferative phase of liver parenchyma at the time of sampling. The same size of 
hepatocytes and no atypical hepatocytes in the biopsies could also be explained by the same 
reason. This hypothesis is supported by restitution of all liver function monitored by 
biochemical parametres at the moment of sacrifying of experimental animals (Liska, 2012).  
The increased number of binucleated hepatocytes in the hypertrophic parenchyma of IL-6 
group in comparison with control group could be explained by incomplete liver 
regeneration at the end of experiment. Because there are practically no mitotic figures or the 
amount is of same quantity as in the normal liver parenchyma without any surgical 
procedures or toxic insult, we could hypothesize, that the first phase of liver regeneration is 
finished and the next phase of regeneration proceeds. It means the remodelation phase and 
the phase, when the liver microstructure is restored. Next would be objective to future study 
– the detection of intracellular or extracellular (matrix) changes during the process of liver 
regeneration. No significant differences in other histological parameters (diameter of 
lobulus and hepatocytes) were not proved (Liska, 2009).  
The larger distribution of the number of binucleated hepatocytes in the hypertrophic 
parenchyma of TGF-ǃ1 group in comparison with the control group could be explained by 
incomplete liver regeneration at the end of experiment. Because there are practically no 
mitotic figures, or the amount is the same as in the normal liver parenchyma without any 
surgical procedures or toxic insult, it was possible to hypothesize that the first phase of liver 
regeneration was finished and the next phase of regeneration was proceeding, namely the 
remodelling phase and the phase when the liver microstructure is restored (Mangnall, 2003). 
The size of hepatocytes and the length of lobuli were not proved to be statistically different 
between study and control group. The same size of hepatocytes and length of lobuli in the 
bioptical samples from the hypertrophic parenchyma could be also explained in the same way. 
This hypothesis is supported by the restitution of all liver functions monitored by biochemical 
parameters and completion of the proliferative phase of liver regeneration at the moment of 
sacrificing of the experimental animals (Liska, 2012).  
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5. Conclusion 
Application of IL-6 and TNF-ǂ augments hypertrophy of FLRV on 7th postoperative day in 
comparison to control group. In case of application of MAB TGF-ǃ1 we observed maximal 
increase of FLRV between 3rd and 7th days. Application of MSC augments hypetrophy of 
FLRV on 3rd day. The biochemical and histological examinations did not prove any 
important differencies among the groups. The use of TNF-ǂ, IL-6, MAB TGF-ǃ1, MSC could 
increase the process of liver regeneration after portal vein ligation.These experimental 
results could be used in clinical practice in patients with risk of acute liver failure after 
extended liver resection.  
6. Summary 
The aim of presented studies was to influence regeneration of liver parenchyma after portal 
vein embolization/ligation. Physiological solution (controls, 9 animals) or TNF-ǂ (9) or 
interleukin-6 (8) or MSC (6) were applied into non-occluded portal vein branches after 
ligation of portal vein branches for right lobes. Administration of MAB TGF-ǃ1 was 
performed 24 hours after ligation (7). Compensatory hypertrophy (FLRV) was followed-up 
in next 14 days by regular ultrasonography, serum level of biochemical parametres and by 
histological examinations. Application of IL-6 and TNF-ǂ augments hypertrophy of FLRV on 
7th postoperative day in comparison to control group. In case of application of MAB TGF-ǃ1 
we observed maximal increase of FLRV between 3rd and 7th days. Application of MSC 
augments hypetrophy of FLRV on 3rd day. The biochemical and histological examinations did 
not prove any differences among the groups. The use of TNF-ǂ, IL-6, MAB TGF-ǃ1, MSC 
could increase the process of liver regeneration after portal vein ligation.  
Keywords: Liver surgery, Liver regeneration, Experimental study, Porcine model, 
Experimental model, Portal vein embolization, TNF-ǂ, Interleukin-6, Mesenchymal stem 
cells, TGF-ǃ1.  
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